This year, about one million beneficiaries of Medicare are expected to receive a cancer diagnosis.
In fact, cancer will claim around 600,000 lives in the US this year.
It’s a leading cause of death, affecting millions of families annually. Research shows that early detection can significantly enhance treatment success, lower expenses, and ultimately save lives. Therefore, investing in early detection makes sense as a public health strategy.
Yet, our healthcare system struggles to keep pace.
Many Americans, particularly those on fixed incomes, already contend with limited access to healthcare, especially in rural areas, and often receive diagnoses at later stages when outcomes are less favorable and treatment costs soar.
Too often, this diagnosis isn’t just a health crisis but also a financial one. I’ve encountered numerous families confronting stark choices: pay for groceries or fund cancer treatments.
Against this backdrop, there are some encouraging developments in Congress.
Last year, members of the House Committee on Ways and Means shared personal stories about how cancer has impacted their lives. They unanimously backed the Nancy Gardner Swell Medicare Multicancer Early Detection Screening Coverage Method.
This makes it notable that this legislation is the first to receive majority backing in both the House and Senate—a level of bipartisan agreement that’s quite rare. Still, the job isn’t finished until the bill is signed into law.
My organization, along with other nonprofits, has witnessed the shortcomings of the system. Rural communities, in particular, experience considerable disparities in timely screening and access to care.
Our findings indicate that longer travel times for treatment often lead to late-stage diagnoses and diminished quality of life. Detecting cancer earlier could change that, giving patients access to proactive (and cost-effective) treatments, and importantly, allowing them more time with family.
However, many types of cancer still lack dependable screening methods. Thus, boosting investments in early detection isn’t just a health imperative but also a financial one.
Finding cancers early tends to be less expensive to treat and increases the chances of survival. One estimate suggests that preventive cancer screenings have saved the US around $6.5 trillion over the past 25 years.
The Nancy Gardner Swell Method aims to modernize Medicare by including cutting-edge screening technologies that can detect numerous cancers through simple blood tests.
This policy represents a pivotal moment in cancer care, particularly for older adults who are at the greatest risk and often face late-stage diagnoses.
The support is substantial. More than 550 organizations, from cancer patients to healthcare providers, are urging lawmakers to act now. Congress has already examined the bill thoroughly, and it’s poised for passage.
As lawmakers return from their summer break, time is of the essence to get this bill across the finish line.
Everything is lined up. The support is there. Now is the moment to act.
